Anadis Limited is a biopharmaceutical research and development company specialising in innovative products containing antibodies and bioactive factors.
Anadis started in 1994 specialising in innovative products containing antibodies and bioactive factors derived from bovine colostrum. Anadis was floated in 1999 on the Australian Stock Exchange. Anadis is looking to the future for new scientific developments and at the acquisition of compatible technologies. Currently the company is evaluating two new "cutting edge" technologies for improving passive and active immunisation procedures.
Partnerships
To view this information, you must subscribe to Partneringtools.
Senior management
To view this information, you must subscribe to Partneringtools.
Board of directors
To view this information, you must subscribe to Partneringtools.
Head office
To view this information, you must subscribe to Partneringtools.